Discover 3,581 paid clinical trials in Irvine, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Clinical trials in Irvine address a diverse range of conditions, from mental health disorders and neurological diseases to skin conditions and cardiovascular issues. As one of California’s thriving research hubs, the city provides participants with a chance to explore cutting-edge therapies and receive specialized care, all while contributing to the advancement of medical science in their region.
Filter
2
Filter results
Results: 3,581
Active & Responsive
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease
for
Late-onset Pompe Disease
Location: Irvine CA, St Louis MO, Durham NC, Fairfax VA
Sponsor: Denali Therapeutics Inc.
Sex: All
Age: 18 - 70+
Code: NCT07354724
Phase1, Recruiting
Active & Responsive
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
for
Metastatic Castration-resistant Prostate Cancer
Location: Newport Beach CA, Omaha NE, Houston TX, Metairie LA,
Sponsor: AstraZeneca
Sex: Male
Age: 18+
Code: NCT07611110
Phase3, Recruiting
Active & Responsive
Lumateperone in the Treatment of Stuttering, Childhood Onset Fluency Disorder
for
Stuttering, Adult
Location: Costa Mesa CA
Sponsor: CSTrials Inc.
Sex: All
Age: 18 - 65
Code: NCT07734103
Phase2, Recruiting
Active & Responsive
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
for
Treatment Resistant Depression
Location: Costa Mesa CA, Los Angeles CA, La Jolla CA,
Sponsor: LivaNova
Sex: All
Age: 18+
Code: NCT03887715
Recruiting
Active & Responsive
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
for
Myasthenia Gravis, Generalized Myasthenia Gravis
Location: Orange CA, Los Angeles CA, Palo Alto CA, Murray UT,
Sponsor: Kyverna Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06193889
Phase2, Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: Orange CA, Long Beach CA, Torrance CA,
Sponsor: Cleerly, Inc.
Sex: All
Age: 55+
Code: NCT06112418
Recruiting
Active & Responsive
ASSESS ALL ALS Study
for
Amyotrophic Lateral Sclerosis
Location: Irvine CA, Los Angeles CA, La Jolla CA, Phoenix AZ,
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix
Sex: All
Age: 18+
Code: NCT06578195
Recruiting
Active & Responsive
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
for
Heart Failure With Preserved Ejection Fraction,
Location: Orange CA, Newport Beach CA, Covina CA, Pomona CA,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07037459
Phase3, Recruiting
Active & Responsive
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
for
Breast Cancer Screening, Breast Carcinoma in Situ,
Location: Irvine CA, Los Angeles CA, San Diego CA,
Sponsor: University of California, San Francisco
Sex: Female
Age: 30 - 70+
Code: NCT02620852
Recruiting
Active & Responsive
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
for
Lupus Nephritis, Systemic Lupus Erythematosus,
Location: Irvine CA, Fullerton CA, Fontana CA, Beverly Hills CA,
Sponsor: Fate Therapeutics
Sex: All
Age: 12 - 70
Code: NCT07570862
Phase2, Recruiting
Active & Responsive
A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDT
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
for
Non-Small Cell Lung Cancer, NSCLC,
Location: Irvine CA, Huntington Beach CA, Duarte CA,
Sponsor: Pierre Fabre Medicament
Sex: All
Age: 18+
Code: NCT06043817
Phase1, Phase2, Recruiting
Active & Responsive
A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.
for
Locally Advanced Pancreatic Adenocarcinoma,
Location: Irvine CA, Duarte CA, Santa Fe NM, Houston TX,
Sponsor: Xerient Pharma
Sex: All
Age: 18+
Code: NCT07157033
Phase1, Phase2, Recruiting
Active & Responsive
Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass
for
Weight Regain, Weight Loss
Location: Irvine CA, Stanford CA, Houston TX, Rochester MN,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT07015424
Recruiting
Active & Responsive
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
for
Castration Resistant Metastatic Prostate Cancer,
Location: Irvine CA, Omaha NE, Kansas City KS, Grand Rapids MI,
Sponsor: Aktis Oncology, Inc.
Sex: Male
Age: 18+
Code: NCT07581184
Phase1, Recruiting
Active & Responsive
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
for
Advanced Esophageal Adenocarcinoma,
Location: Irvine CA, Anaheim CA, Bellflower CA, Riverside CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06203600
Phase2, Phase3, Recruiting
Active & Responsive
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
for
Cancer, Metastatic, Cancer, Cancer of Pancreas, Cancer of Liver,
Location: Irvine CA, Orange CA, Duarte CA, Scottsdale AZ,
Sponsor: Massive Bio, Inc.
Sex: All
Age: 0+
Code: NCT03452774
Recruiting
Active & Responsive
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
for
Plaque Psoriasis
Location: Santa Ana CA, Fountain Valley CA, Los Angeles CA,
Sponsor: Oruka Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07449702
Phase2, Recruiting
Active & Responsive
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)